Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Stomatitis associated with mammalian target of rapamycin inhibition: A review of pathogenesis, prevention, treatment, and clinical implications for oral practice in metastatic breast cancer.

Chambers MS, Rugo HS, Litton JK, Meiller TF.

J Am Dent Assoc. 2018 Apr;149(4):291-298. doi: 10.1016/j.adaj.2017.10.024. Epub 2018 Feb 10.

PMID:
29439772
2.

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, phase 2 trial.

Rugo HS, Seneviratne L, Beck JT, Glaspy JA, Peguero JA, Pluard TJ, Dhillon N, Hwang LC, Nangia C, Mayer IA, Meiller TF, Chambers MS, Sweetman RW, Sabo JR, Litton JK.

Lancet Oncol. 2017 May;18(5):654-662. doi: 10.1016/S1470-2045(17)30109-2. Epub 2017 Mar 15.

PMID:
28314691
3.

Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice.

Peterson DE, O'Shaughnessy JA, Rugo HS, Elad S, Schubert MM, Viet CT, Campbell-Baird C, Hronek J, Seery V, Divers J, Glaspy J, Schmidt BL, Meiller TF.

Cancer Med. 2016 Aug;5(8):1897-907. doi: 10.1002/cam4.761. Epub 2016 Jun 23. Review.

4.

Alternative Therapeutic Approach in the Treatment of Oral Pyogenic Granuloma.

Bugshan A, Patel H, Garber K, Meiller TF.

Case Rep Oncol. 2015 Nov 14;8(3):493-7. doi: 10.1159/000441839. eCollection 2015 Sep-Dec.

5.

Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Kong EF, Tsui C, Boyce H, Ibrahim A, Hoag SW, Karlsson AJ, Meiller TF, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):881-9. doi: 10.1128/AAC.02624-15. Print 2016 Feb.

6.

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series.

Meiller TF, Varlotta S, Weikel D.

Case Rep Oncol. 2015 Aug 19;8(2):369-77. doi: 10.1159/000438747. eCollection 2015 May-Aug.

7.

Periodontal Diseases: Bug Induced, Host Promoted.

Khan SA, Kong EF, Meiller TF, Jabra-Rizk MA.

PLoS Pathog. 2015 Jul 30;11(7):e1004952. doi: 10.1371/journal.ppat.1004952. eCollection 2015 Jul. Review. No abstract available.

8.

Lactoferrin levels in gingival crevicular fluid and saliva of HIV-infected patients with chronic periodontitis.

Ferreira SM, Gonçalves LS, Torres SR, Nogueira SA, Meiller TF.

J Investig Clin Dent. 2015 Feb;6(1):16-24. doi: 10.1111/jicd.12017. Epub 2014 Oct 21.

PMID:
25331852
9.

Altered structure and function in the hippocampus and medial prefrontal cortex in patients with burning mouth syndrome.

Khan SA, Keaser ML, Meiller TF, Seminowicz DA.

Pain. 2014 Aug;155(8):1472-80. doi: 10.1016/j.pain.2014.04.022. Epub 2014 Apr 24.

PMID:
24769366
10.

Impaired Histatin-5 Levels and Salivary Antimicrobial Activity against C. albicans in HIV Infected Individuals.

Khan SA, Fidel PL Jr, Thunayyan AA, Varlotta S, Meiller TF, Jabra-Rizk MA.

J AIDS Clin Res. 2013 Mar 5;4(193). pii: 1000193.

11.

A review of common oral pathology lesions, with a focus on periodontology and implantology.

Meiller TF, Garber K, Scheper M.

J Evid Based Dent Pract. 2012 Sep;12(3 Suppl):254-62. doi: 10.1016/S1532-3382(12)70049-0. Review.

PMID:
23040352
12.

Bisphosphonate-associated osteonecrosis of the jaw: are we dealing with a localized non-traditional calciphylaxis?

Meiller T, Almubarak H, Weikel D, Brahim J, Scheper M.

Open Dent J. 2012;6:5-7. doi: 10.2174/1874210601206010005. Epub 2012 Jan 12.

13.

Zoledronic acid directly suppresses cell proliferation and induces apoptosis in highly tumorigenic prostate and breast cancers.

Almubarak H, Jones A, Chaisuparat R, Zhang M, Meiller TF, Scheper MA.

J Carcinog. 2011 Jan 15;10:2. doi: 10.4103/1477-3163.75723. Retraction in: J Carcinog. 2015 Feb 23;14:2.

14.

A case of a deeply fissured tongue.

Binmadi NO, Jham BC, Meiller TF, Scheper MA.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):659-63. doi: 10.1016/j.tripleo.2010.01.016. No abstract available.

PMID:
20416535
15.

A novel soft-tissue in vitro model for bisphosphonate-associated osteonecrosis.

Scheper M, Chaisuparat R, Cullen K, Meiller T.

Fibrogenesis Tissue Repair. 2010 Apr 1;3:6. doi: 10.1186/1755-1536-3-6.

16.

A novel bioassay model to determine clinically significant bisphosphonate levels.

Scheper MA, Badros A, Salama AR, Warburton G, Cullen KJ, Weikel DS, Meiller TF.

Support Care Cancer. 2009 Dec;17(12):1553-7. doi: 10.1007/s00520-009-0710-7. Epub 2009 Aug 4.

PMID:
19653010
17.

A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide.

Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, Winkler R, Ton A, Jabra-Rizk MA.

PLoS One. 2009;4(4):e5039. doi: 10.1371/journal.pone.0005039. Epub 2009 Apr 7.

18.

Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.

Scheper MA, Badros A, Chaisuparat R, Cullen KJ, Meiller TF.

Br J Haematol. 2009 Mar;144(5):667-76. doi: 10.1111/j.1365-2141.2008.07504.x. Epub 2008 Nov 20.

19.

Salivary histatin-5 and oral fungal colonisation in HIV+ individuals.

Torres SR, Garzino-Demo A, Meiller TF, Meeks V, Jabra-Rizk MA.

Mycoses. 2009 Jan;52(1):11-5. doi: 10.1111/j.1439-0507.2008.01602.x. Epub 2008 Oct 18. Review.

PMID:
18983435
20.

A diffuse but subtle swelling of the upper lip.

Jham BC, Meiller TF, King M, Scheper MA.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Dec;106(6):773-7. doi: 10.1016/j.tripleo.2008.06.020. Epub 2008 Aug 28. No abstract available.

PMID:
18755617
21.

Farnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cells.

Scheper MA, Shirtliff ME, Meiller TF, Peters BM, Jabra-Rizk MA.

Neoplasia. 2008 Sep;10(9):954-63.

22.

Candida dubliniensis and Candida albicans display surface variations consistent with observed intergeneric coaggregation.

Jabra-Rizk MA, Falkler WA Jr, Merz WG, Kelley JI, Baqui AA, Meiller TF.

Rev Iberoam Micol. 1999 Dec;16(4):187-93.

23.

A stable swelling of the hard palate.

Scheper MA, Nikitakis NG, Meiller TF.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Oct;104(4):461-4. Epub 2007 Jul 13. No abstract available.

PMID:
17629518
24.

Prevalence of oral Candida species ina North American pediatric population.

Jabra-Rizk MA, Torres SR, Rambob I, Meiller TF, Grossman LK, Minah G.

J Clin Pediatr Dent. 2007 Summer;31(4):260-3.

PMID:
19161062
25.

The effect of a mouthrinse containing essential oils on dental restorative materials.

von Fraunhofer JA, Kelley JI, DePaola LG, Meiller TF.

Gen Dent. 2006 Nov-Dec;54(6):403-7.

PMID:
17134077
26.

Cowden syndrome: report of a case with immunohistochemical analysis and review of the literature.

Scheper MA, Nikitakis NG, Sarlani E, Sauk JJ, Meiller TF.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 May;101(5):625-31. Epub 2006 Jan 10. Review.

PMID:
16632275
27.

Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility.

Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME.

Antimicrob Agents Chemother. 2006 Apr;50(4):1463-9.

28.

Prevalence of Candida dubliniensis fungemia at a large teaching hospital.

Jabra-Rizk MA, Johnson JK, Forrest G, Mankes K, Meiller TF, Venezia RA.

Clin Infect Dis. 2005 Oct 1;41(7):1064-7. Epub 2005 Aug 30.

PMID:
16142677
29.

Efficacy of Listerine Antiseptic in reducing viral contamination of saliva.

Meiller TF, Silva A, Ferreira SM, Jabra-Rizk MA, Kelley JI, DePaola LG.

J Clin Periodontol. 2005 Apr;32(4):341-6.

PMID:
15811049
30.

Effect of a dental unit waterline additive on resin bond strengths.

von Fraunhofer JA, DePaola LG, Kelley JI, Meiller TF.

Gen Dent. 2004 Nov-Dec;52(6):502-4.

PMID:
15636273
31.

Superficial mucocele of the labial mucosa: a case report and review of the literature.

Silva A Jr, Nikitakis NG, Balciunas BA, Meiller TF.

Gen Dent. 2004 Sep-Oct;52(5):424-7. Review.

PMID:
15544220
32.

Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells.

Jabra-Rizk MA, Falkler WA Jr, Merz WG, Baqui AA, Kelley JI, Meiller TF.

Rev Iberoam Micol. 2001 Mar;18(1):17-22.

33.

Effect of a dental unit waterline treatment solution on composite-dentin shear bond strengths.

von Fraunhofer JA, Kelley JI, DePaola LG, Meiller TF.

J Clin Dent. 2004;15(1):28-32.

PMID:
15218713
34.
35.

Fungal biofilms and drug resistance.

Jabra-Rizk MA, Falkler WA, Meiller TF.

Emerg Infect Dis. 2004 Jan;10(1):14-9. Review.

36.

Fungal drug resistance, biofilms, and new antifungals.

Wynn RL, Jabra-Rizk MA, Meiller TF.

Gen Dent. 2003 Mar-Apr;51(2):94-8. Review. No abstract available.

PMID:
15055679
37.

Paresthesia associated with local anesthetics: a perspective on articaine.

Wynn RL, Bergman SA, Meiller TF.

Gen Dent. 2003 Nov-Dec;51(6):498-501. No abstract available.

PMID:
15055644
38.

Pharmacotherapy for breast cancer: a short primer for the dentist.

Wynn RL, Weikel DS, Tait N, Meiller TF.

Gen Dent. 2003 Jul-Aug;51(4):306-9. No abstract available.

PMID:
15055603
39.

The histidine kinases of Candida albicans: regulation of cell wall mannan biosynthesis.

Kruppa M, Jabra-Rizk MA, Meiller TF, Calderone R.

FEMS Yeast Res. 2004 Jan;4(4-5):409-16.

40.

Antibiotics in treating oral-facial infections of odontogenic origin: an update.

Wynn RL, Bergman SA, Meiller TF, Crossley HL.

Gen Dent. 2001 May-Jun;49(3):238-40, 242, 244 passim. No abstract available.

PMID:
12004720
41.

Drugs and dry mouth.

Wynn RL, Meiller TF.

Gen Dent. 2001 Jan-Feb;49(1):10-2, 14. No abstract available.

PMID:
12004670
42.

Artificial saliva products and drugs to treat xerostomia.

Wynn RL, Meiller TF.

Gen Dent. 2000 Nov-Dec;48(6):630-6. No abstract available.

PMID:
12004654
43.

Prevalence of yeast among children in Nigeria and the United States.

Jabra-Rizk MA, Falkler WA Jr, Enwonwu CO, Onwujekwe DI Jr, Merz WG, Meiller TF.

Oral Microbiol Immunol. 2001 Dec;16(6):383-5.

PMID:
11737663
44.

Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions.

Jabra-Rizk MA, Ferreira SM, Sabet M, Falkler WA, Merz WG, Meiller TF.

J Clin Microbiol. 2001 Dec;39(12):4520-2.

45.

Laboratory evaluation of anti-biofilm agents for use in dental unit waterlines.

Meiller TF, Kelley JI, Baqui AA, DePaola LG.

J Clin Dent. 2001;12(4):97-103.

PMID:
11507923
46.

Disinfection of dental unit waterlines with an oral antiseptic.

Meiller TF, Kelley JI, Baqui AA, DePaola LG.

J Clin Dent. 2000;11(1):11-5.

PMID:
11460287
47.

In vitro effect of oral antiseptics on human immunodeficiency virus-1 and herpes simplex virus type 1.

Baqui AA, Kelley JI, Jabra-Rizk MA, Depaola LG, Falkler WA, Meiller TF.

J Clin Periodontol. 2001 Jul;28(7):610-6.

PMID:
11422581
48.

In vitro studies of the efficacy of antimicrobials against fungi.

Meiller TF, Kelley JI, Jabra-Rizk MA, Depaola LG, Baqui AA, Falkler WA Jr.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):663-70.

PMID:
11402279
49.

New assay for measuring cell surface hydrophobicities of Candida dubliniensis and Candida albicans.

Jabra-Rizk MA, Falkler WA Jr, Merz WG, Meiller TF.

Clin Diagn Lab Immunol. 2001 May;8(3):585-7.

50.

Evaluation of a reformulated CHROMagar Candida.

Jabra-Rizk MA, Brenner TM, Romagnoli M, Baqui AA, Merz WG, Falkler WA Jr, Meiller TF.

J Clin Microbiol. 2001 May;39(5):2015-6.

Supplemental Content

Loading ...
Support Center